RTP Mobile Logo

First-Line Erlotinib with or without Chemotherapy for Never or Light Smokers with Advanced Non-Small Cell Lung Cancer (NSCLC)

CME test Downloadable PDF PowerPoint slides CME Information and Faculty Disclosures
Read Dr Love's original email (from July 30, 2010) Subscribe to Dr Love's email alerts
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Roy S Herbst, MD, PhD (6/23/10), Corey J Langer, MD (7/2/10) and Mark A Socinski, MD (6/4/10)
 

Jänne PA et al. Randomized phase II trial of erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in never or light former smokers with advanced lung adenocarcinoma: CALGB 30406. Proc ASCO 2010;Abstract 7503.

 

Go to previous Journal Club